SCHEMBL6839377

SCHEMBL6839377

COC(=O)NC1CCc2c(ccc(OC)c2OC)C1=O

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.57
LMNA P02545 4/20 0.57
POLB P06746 1/20 0.57
MAPT P10636 1/20 0.57
ACHE P22303 1/20 0.50
ALDH1A1 P00352 1/20 0.50
HPGD P15428 1/20 0.50
TUBB1 Q9H4B7 5/20 0.43
CYP2C9 P11712 3/20 0.43
TUBB4A P04350 3/20 0.43
TUBB P07437 3/20 0.43
TUBA3C P0DPH7 3/20 0.43
TUBA1B P68363 3/20 0.43
TUBA4A P68366 3/20 0.43
TUBB4B P68371 3/20 0.43
TUBB3 Q13509 3/20 0.43
TUBB2A Q13885 3/20 0.43
TUBB8 Q3ZCM7 3/20 0.43
TUBA3E Q6PEY2 3/20 0.43
TUBA1A Q71U36 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11720868 0.90 LMNA (0.71) KDM4ELMNAPOLBMAPTACHE
SCHEMBL8960032 0.85 LMNA (0.53) KDM4ELMNAPOLBMAPTACHE
SCHEMBL11595431 0.84 KDM4E (0.55) KDM4ELMNAPOLBMAPTACHE
SCHEMBL27371740 0.84 KDM4E (0.55) KDM4ELMNAPOLBMAPTACHE
Hydrochloric Acid SCHEMBL7337871 0.83 KDM4E (0.54) KDM4ELMNAPOLBMAPTACHE
Hydrochloric Acid SCHEMBL11713840 0.80 KDM4E (0.50) KDM4ELMNAPOLBMAPTACHE
Hydrochloric Acid SCHEMBL11596029 0.79 KDM4E (0.49) KDM4ELMNAPOLBMAPTACHE
Hydrochloric Acid SCHEMBL11593918 0.79 KDM4E (0.49) KDM4ELMNAPOLBMAPTACHE
Hydrochloric Acid SCHEMBL11595883 0.78 KDM4E (0.51) KDM4ELMNAPOLBMAPTACHE
SCHEMBL10864144 0.76 KDM4E (0.59) KDM4ELMNAPOLBMAPTACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040102652-A1 Optically active2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them CHIESI FARMACEUTICI S.P.A. (IT) 2004-05-27 US disclosed
CN-1137085-C Process for preparation of 5,6-dihydroxyl-2-amino-1,2,3,4-tetrahydronaphthalene derivatives ������˹ҩƷ��˾ 2004-02-04 CN disclosed
CN-1073984-C Process for preparing 5, 6-dihydroxy-2-amino-1, 2,3, 4-tetrahydronaphthalene derivatives CHIESI FARMA SPA (IT) 2001-10-31 CN disclosed
CN-1278528-A Process for preparation of 5,6-dihydroxyl-2-amino-1,2,3,4-tetrahydronaphthalene derivatives CHIESI PHARMACEUTICAL S P A (IT) 2001-01-03 CN disclosed
CN-1278526-A Process for preparation of 5,6-dihydroxyl-2-amino-1,2,3,4-tetrahydronaphthalene derivatives CHIESI PHARMACEUTICAL S P A (IT) 2001-01-03 CN disclosed
CN-1278527-A Process for preparation of 5,6-dihydrxyl-2-amino-1,2,3,4-tetrahydronaphthalene derivatives CHIESI PHARMACEUTICAL S P A (IT) 2001-01-03 CN disclosed
EP-0788472-B1 A PROCESS FOR THE PREPARATION OF 5,6-DIHYDROXY-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES CHIESI FARMA SPA (IT) 2000-08-02 EP disclosed
US-6034277-A Process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives CHIESI FARMACEUTICI S.P.A. (IT) 2000-03-07 US disclosed
US-5936125-A Process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives CHIESI FARMACEUTICI S.P.A. (IT) 1999-08-10 US disclosed
US-5710336-A Process for the preparation of 5-6-dihydroxy-2-amino-1, 2, 3, 4-tetrahydronaphthalene derivatives CHIESI FARMACEUTICI S.P.A. (IT) 1998-01-20 US disclosed
EP-0788472-A1 A PROCESS FOR THE PREPARATION OF 5,6-DIHYDROXY-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES CHIESI FARMACEUTICI S.p.A. (IT) 1997-08-13 EP disclosed
CN-1147808-A Process for preparing 5, 6-dihydroxy-2-amino-1, 2, 3, 4-tetrahydronaphthalene derivatives CHIESI FARMA SPA (IT) 1997-04-16 CN disclosed
WO-1995029147-A1 A PROCESS FOR THE PREPARATION OF 5,6-DIHYDROXY-2-AMINO-1,2,3,4-TETRAHYDRONAPHTHALENE DERIVATIVES CHIESI FARMACEUTICI S.P.A. (IT) 1995-11-02 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040102652-A1 Optically active2-aminotetralin derivatives, the processes for the preparation thereof and the therapeutical use of pharmaceutical compositions containing them AADAT, AASDHPPT, AAAS KDM4E 1637/4885LMNA 1606/4885POLB 3257/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.